BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 9164527)

  • 1. Early detection of recurrent hepatocellular carcinoma.
    Nishizaki T; Takenaka K; Yanaga K; Soejima Y; Uchiyama H; Kishikawa K; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):508-13. PubMed ID: 9164527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early intrahepatic recurrence of hepatocellular carcinoma after hepatectomy treated with re-hepatectomy, ablation or chemoembolization: a prospective cohort study.
    Wang K; Liu G; Li J; Yan Z; Xia Y; Wan X; Ji Y; Lau WY; Wu M; Shen F
    Eur J Surg Oncol; 2015 Feb; 41(2):236-42. PubMed ID: 25434327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma.
    Shimada K; Sakamoto Y; Esaki M; Kosuge T; Morizane C; Ikeda M; Ueno H; Okusaka T; Arai Y; Takayasu K
    Ann Surg Oncol; 2007 Aug; 14(8):2337-47. PubMed ID: 17503155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of alpha-fetoprotein mRNA in peripheral blood in liver resection for hepatocellular carcinoma.
    Marubashi S; Nagano H; Wada H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
    Ann Surg Oncol; 2011 Aug; 18(8):2200-9. PubMed ID: 21301972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection.
    Yamanaka J; Yamanaka N; Nakasho K; Tanaka T; Ando T; Yasui C; Kuroda N; Takata M; Maeda S; Matsushita K; Uematsu K; Okamoto E
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1192-8. PubMed ID: 11106101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.
    Ma WJ; Wang HY; Teng LS
    World J Surg Oncol; 2013 Aug; 11():212. PubMed ID: 23981851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
    Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strategy for early detection of recurrent hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization.
    Chung YH
    Intervirology; 2005; 48(1):46-51. PubMed ID: 15785089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum alpha fetoprotein in patients with recurrent hepatocellular carcinoma following hepatectomy.
    Liu G; Wang K; Li J; Xia Y; Lu L; Wan X; Yan Z; Shi L; Lau WY; Wu M; Shen F
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1405-11. PubMed ID: 25801981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of pattern and treatment of intrahepatic recurrence after resection of hepatocellular carcinoma.
    Nagasue N; Yukaya H; Chang YC; Yamanoi A; Kohno H; Hayashi T; Nakamura T
    Surg Gynecol Obstet; 1990 Sep; 171(3):217-22. PubMed ID: 1696750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization.
    Lee JK; Chung YH; Song BC; Shin JW; Choi WB; Yang SH; Yoon HK; Sung KB; Lee YS; Suh DJ
    J Gastroenterol Hepatol; 2002 Jan; 17(1):52-8. PubMed ID: 11895553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation.
    Siripongsakun S; Wei SH; Lin S; Chen J; Raman SS; Sayre J; Tong MJ; Lu DS
    J Gastroenterol Hepatol; 2014 Jan; 29(1):157-64. PubMed ID: 24354994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old.
    Taura K; Ikai I; Hatano E; Fujii H; Uyama N; Shimahara Y
    Ann Surg; 2006 Aug; 244(2):265-73. PubMed ID: 16858190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening.
    Tseng PL; Wang JH; Tung HD; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen PF; Tsai LS; Lu SN
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1426-34. PubMed ID: 20659234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
    Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
    Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy.
    Lu X; Zhao H; Yang H; Mao Y; Sang X; Miao R; Xu Y; Du S; Xu H; Chi T; Yang Z; Zhong S; Huang J
    J Surg Oncol; 2009 Nov; 100(6):488-93. PubMed ID: 19653238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.
    Shim JH; Yoon DL; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
    Ann Surg Oncol; 2012 Nov; 19(12):3687-96. PubMed ID: 22644512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
    Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
    J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection.
    Zhang XF; Lai EC; Kang XY; Qian HH; Zhou YM; Shi LH; Shen F; Yang YF; Zhang Y; Lau WY; Wu MC; Yin ZF
    Ann Surg Oncol; 2011 Aug; 18(8):2218-23. PubMed ID: 21336512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.